Immunic AG | WebDisclosure

Basculer en Français

10656	Companies
226807	Keywords
155246	Articles
120075	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 06/24/2025 at 12:30, 1 year ago

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
Immunic reports positive long-term data from phase 2 EMPhASIS Trial of Vidofludimus Calcium in relapsing-remitting multiple sclerosis, showing favorable safety & tolerability profile up to 5.5 years

Multiple Sclerosis Immunic Vidofludimus Calcium Safety EMPhASIS Trial
BRIEF

published on 06/05/2025 at 12:35, 1 year ago

Immunic Completes Phase 3 ENSURE Trials Enrollment for MS

Immunic Vidofludimus Calcium Phase 3 Neuroprotection MS Trials
BRIEF

published on 06/05/2025 at 12:35, 1 year ago

Immunic finalise le recrutement pour les essais ENSURE de phase 3 pour la sclérose en plaques

Phase 3 Neuroprotection Essais Sur La Sclérose En Plaques Immunique Vidofludimus Calcique
PRESS RELEASE

published on 06/05/2025 at 12:30, 1 year ago

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS
Immunic completes enrollment for Phase 3 ENSURE trials in Relapsing MS and presents positive Phase 2 CALLIPER trial data in Progressive MS, showcasing vidofludimus calcium's potential. Top-line data in 2026

Immunic Vidofludimus Calcium Phase 3 ENSURE Trials Phase 2 CALLIPER Trial Relapsing MS
BRIEF

published on 06/02/2025 at 12:35, 1 year ago

Immunic to Attend Key Conferences in June

Biotechnology Conférences Immunic Vidofludimus Calcium Investor Meetings
BRIEF

published on 06/02/2025 at 12:35, 1 year ago

Immunic participera à des conférences clés en juin

Biotechnologie Conférences Réunions D'investisseurs Immunique Vidofludimus Calcique
PRESS RELEASE

published on 06/02/2025 at 12:30, 1 year ago

Immunic to Participate in Investor, Scientific and Industry Conferences in June
Immunic, Inc. to participate in multiple investor, scientific, and industry conferences in June 2025, presenting research and clinical pipeline updates

Biotechnology Conférences Scientific Research Immunic Inc. Clinical Pipeline
BRIEF

published on 05/02/2025 at 12:35, 1 year 1 month ago

Immunic to Engage in Key Conferences in May

Clinical Trials Conférences Multiple Sclerosis Immunic Celiac Disease
BRIEF

published on 05/02/2025 at 12:35, 1 year 1 month ago

Immunic participera à des conférences clés en mai

Conférences Essais Cliniques Sclérose En Plaques Immunique Maladie Cœliaque
PRESS RELEASE

published on 05/02/2025 at 12:30, 1 year 1 month ago

Immunic to Participate in Scientific and Industry Conferences in May
Immunic to participate in scientific and industry conferences in May, including DDW and CMSC Annual Meeting 2025, presenting on IMU-856 and vidofludimus calcium for autoimmune diseases

Immunic Autoimmune Diseases Industry Conferences Scientific Conferences IMU-856

Accesswire

Published on 06/29/2026 at 15:00, 2 hours 28 minutes ago

Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 2 hours 28 minutes ago

Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 2 hours 58 minutes ago

Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 2 hours 58 minutes ago

Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 14:30, 2 hours 58 minutes ago

US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher

View all ACCESSWIRE

EQS Group

Published on 06/29/2026 at 16:48, 40 minutes ago

Amprion successfully signs €6.5 billion “Energiewende Green Revolving Credit Facility”
Published on 06/29/2026 at 16:45, 43 minutes ago

World's First Commercial Multimodal LLM for Cultural Tourism Enters Broad Application
Published on 06/29/2026 at 16:30, 58 minutes ago

EUROPLASMA: Communiqué de presse
Published on 06/29/2026 at 16:29, 58 minutes ago

Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
Published on 06/29/2026 at 16:29, 59 minutes ago

Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities

Les Echos

Published on 06/29/2026 at 16:39, 49 minutes ago

Statement of transactions in own shares from June 22, 2026 to June 26, 2026
Published on 06/29/2026 at 16:39, 49 minutes ago

Déclaration des transactions sur actions propres réalisées du 22/06/2026 au 26/06/2026
Published on 06/29/2026 at 16:30, 58 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 06/29/2026 at 16:30, 58 minutes ago

Capital increase through exercise of subscription rights
Published on 06/29/2026 at 10:56, 6 hours 32 minutes ago

GUILLEMOT CORPORATION S.A. | Déclaration hebdomadaire des transactions sur actions propres du 22 au 26 juin 2026

View all LES ECHOS COMFI WIRE